Organisation paid for research Program year 2024 Source: CMS Open Payments

Ace Clinical Trials

Neither a doctor nor a teaching hospital

Research payments

$74,710

7 payments

Through program year 2024, Ace Clinical Trials is reported as receiving $74,710 in research payments, across 7 payments.

By program year

2 rows
Year Kind Amount Payments
2024 Research $72,742 6
2023 Research $1,968 1

Breakdown

Who paid Research payments · program years 2023–2024
  1. Amgen Inc. $74,710 7 payments
Studies the money was for Research payments · program years 2023–2024
  1. ASTRO P3 AD Adolescent Mono $28,515 2 payments
  2. ASCEND P3 AD Extension $25,339 2 payments
  3. HORIZON P3 AD Monotherapy Induction $18,889 2 payments
  4. P3 AD Monotherapy Induction $1,968 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record